DalsnaFinance › IPOs › SpyGlass Pharma › IPO
SpyGlass Pharma, Inc. completed its initial public offering on NASDAQ on February 6, 2026, pricing at $16.00 a share.
| Ticker | SGP |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | February 6, 2026 |
| Offering price | $16.00 |
| Shares offered | 9,375,000 |
| Total raised | $150M |
SpyGlass Pharma, Inc. sold 9,375,000 shares at $16.00 each on NASDAQ. Multiplied out, that is $150 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $150 million total recorded for the deal.
Measured by money raised, SpyGlass Pharma, Inc. was tied for the 268th largest (level with 33 other deals) of 473 completed IPOs with a recorded deal size that this site tracks since October 5, 2024. The median deal in the same window raised $200 million.
Among the 342 listings on NASDAQ alone, it is tied for the 195th largest (level with 28 other listings).
February 2026 saw 41 completed IPOs in the site's data; by amount raised, SpyGlass Pharma, Inc. was tied for the 27th largest (level with 3 other deals) of the 41 deals with a recorded size.
Its $16.00 offer price was tied for the 109th highest (level with 11 other listings) of the 479 listings in the window with a recorded price. A share price on its own says nothing about a company's value; it depends on how many shares exist.
SpyGlass Pharma, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for SpyGlass Pharma, Inc.. This page is general information, not investment advice.